2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine

C178H134N16O2S2 — CID 157289302

IUPAC2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine
SMILESCC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5ccccc5n4-c4ccccc4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4ccccc4n3-c3ccccc3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5ccccc5s4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4ccccc4s3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5cccnc5o4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4cccnc4o3)c2)c2ccccc21
InChIInChI=1S/C68H52N6.C56H42N4S2.C54H40N6O2/c1-67(2)53-27-11-17-33-59(53)71(60-34-18-12-28-54(60)67)51-41-45(39-47(43-51)65-69-57-31-15-21-37-63(57)73(65)49-23-7-5-8-24-49)46-40-48(66-70-58-32-16-22-38-64(58)74(66)50-25-9-6-10-26-50)44-52(42-46)72-61-35-19-13-29-55(61)68(3,4)56-30-14-20-36-62(56)72;1-55(2)41-17-5-11-23-47(41)59(48-24-12-6-18-42(48)55)39-31-35(29-37(33-39)53-57-45-21-9-15-27-51(45)61-53)36-30-38(54-58-46-22-10-16-28-52(46)62-54)34-40(32-36)60-49-25-13-7-19-43(49)56(3,4)44-20-8-14-26-50(44)60;1-53(2)39-15-5-9-21-45(39)59(46-22-10-6-16-40(46)53)37-29-33(27-35(31-37)49-57-43-19-13-25-55-51(43)61-49)34-28-36(50-58-44-20-14-26-56-52(44)62-50)32-38(30-34)60-47-23-11-7-17-41(47)54(3,4)42-18-8-12-24-48(42)60/h5-44H,1-4H3;5-34H,1-4H3;5-32H,1-4H3
InChIKeyBAPOSERUGCNRBY-UHFFFAOYSA-N
MW2593.27 g/mol
LogP47.69
Rot. Bonds17

About 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine

2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine (PubChem CID 157289302) has the molecular formula C178H134N16O2S2 and a molecular weight of 2593.27 g/mol. Its IUPAC name is 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine.

Molecular Properties

Compound Name2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine
PubChem CID157289302
Molecular FormulaC178H134N16O2S2
Molecular Weight2593.27 g/mol
Exact Mass2591.03
IUPAC Name2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine
SMILESCC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5ccccc5n4-c4ccccc4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4ccccc4n3-c3ccccc3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5ccccc5s4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4ccccc4s3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5cccnc5o4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4cccnc4o3)c2)c2ccccc21
InChIInChI=1S/C68H52N6.C56H42N4S2.C54H40N6O2/c1-67(2)53-27-11-17-33-59(53)71(60-34-18-12-28-54(60)67)51-41-45(39-47(43-51)65-69-57-31-15-21-37-63(57)73(65)49-23-7-5-8-24-49)46-40-48(66-70-58-32-16-22-38-64(58)74(66)50-25-9-6-10-26-50)44-52(42-46)72-61-35-19-13-29-55(61)68(3,4)56-30-14-20-36-62(56)72;1-55(2)41-17-5-11-23-47(41)59(48-24-12-6-18-42(48)55)39-31-35(29-37(33-39)53-57-45-21-9-15-27-51(45)61-53)36-30-38(54-58-46-22-10-16-28-52(46)62-54)34-40(32-36)60-49-25-13-7-19-43(49)56(3,4)44-20-8-14-26-50(44)60;1-53(2)39-15-5-9-21-45(39)59(46-22-10-6-16-40(46)53)37-29-33(27-35(31-37)49-57-43-19-13-25-55-51(43)61-49)34-28-36(50-58-44-20-14-26-56-52(44)62-50)32-38(30-34)60-47-23-11-7-17-41(47)54(3,4)42-18-8-12-24-48(42)60/h5-44H,1-4H3;5-34H,1-4H3;5-32H,1-4H3
InChIKeyBAPOSERUGCNRBY-UHFFFAOYSA-N
XLogP47.69
TPSA158.70 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds17
Heavy Atoms198
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002593.27
LogP ≤ 547.69
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Analyze 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine?
The IUPAC name of 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine (CID 157289302) is 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine.
What is the SMILES notation for 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine?
The canonical SMILES for 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine is CC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5ccccc5n4-c4ccccc4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4ccccc4n3-c3ccccc3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5ccccc5s4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4ccccc4s3)c2)c2ccccc21.CC1(C)c2ccccc2N(c2cc(-c3cc(-c4nc5cccnc5o4)cc(N4c5ccccc5C(C)(C)c5ccccc54)c3)cc(-c3nc4cccnc4o3)c2)c2ccccc21.
What is the InChIKey of 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine?
The InChIKey is BAPOSERUGCNRBY-UHFFFAOYSA-N. The full InChI is InChI=1S/C68H52N6.C56H42N4S2.C54H40N6O2/c1-67(2)53-27-11-17-33-59(53)71(60-34-18-12-28-54(60)67)51-41-45(39-47(43-51)65-69-57-31-15-21-37-63(57)73(65)49-23-7-5-8-24-49)46-40-48(66-70-58-32-16-22-38-64(58)74(66)50-25-9-6-10-26-50)44-52(42-46)72-61-35-19-13-29-55(61)68(3,4)56-30-14-20-36-62(56)72;1-55(2)41-17-5-11-23-47(41)59(48-24-12-6-18-42(48)55)39-31-35(29-37(33-39)53-57-45-21-9-15-27-51(45)61-53)36-30-38(54-58-46-22-10-16-28-52(46)62-54)34-40(32-36)60-49-25-13-7-19-43(49)56(3,4)44-20-8-14-26-50(44)60;1-53(2)39-15-5-9-21-45(39)59(46-22-10-6-16-40(46)53)37-29-33(27-35(31-37)49-57-43-19-13-25-55-51(43)61-49)34-28-36(50-58-44-20-14-26-56-52(44)62-50)32-38(30-34)60-47-23-11-7-17-41(47)54(3,4)42-18-8-12-24-48(42)60/h5-44H,1-4H3;5-34H,1-4H3;5-32H,1-4H3.
What are the key properties of 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine?
2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine has a molecular weight of 2593.27 g/mol, XLogP of 47.69, 17 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[3-(1,3-benzothiazol-2-yl)-5-(9,9-dimethylacridin-10-yl)phenyl]-5-(9,9-dimethylacridin-10-yl)phenyl]-1,3-benzothiazole;2-[3-(9,9-dimethylacridin-10-yl)-5-[3-(9,9-dimethylacridin-10-yl)-5-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]phenyl]-[1,3]oxazolo[5,4-b]pyridine;10-[3-[3-(9,9-dimethylacridin-10-yl)-5-(1-phenylbenzimidazol-2-yl)phenyl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-9,9-dimethylacridine is sourced from PubChem (CID 157289302), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).